ANNE PRICE: Open Payments
NPI 1356864789 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 20 payments from 14 companies in 2025. Trend: 2023 $437 · 2024 $530 · 2025 $660
Food & beverage: $595Education: $65
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 1 | $150 |
| Incyte Corporation | 4 | $148 |
| Celgene Corporation | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| ARRAY BIOPHARMA INC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Deciphera Pharmaceuticals Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: COSELA, JAKAFI, REBLOZYL, KEYTRUDA, BRAFTOVI, CALQUENCE, QINLOCK, Xtandi.
Industry payments across TX — which companies pay providers there.
